{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-068800","form_type":"8-K","ticker":"URGN","cik":"0001668243","company_name":"UroGen Pharma Ltd.","filed_at":"2022-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.724095+00:00","generated_at":"2026-06-27T00:48:57.056002+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"UroGen Pharma enters $100M term loan facility with BPCR Limited Partnership","bullets":["Term loans up to $100M; Tranche A $75M at closing, Tranche B $25M optional by Dec 31, 2022.","Interest rate 8.25% + 3-month LIBOR (floor 1.25%); quarterly interest; principal amortization starts after 17th quarter.","Secured by substantially all assets; no financial covenants; prepayment premiums (3%/2%/1%) and makewhole provisions.","Proceeds for general corporate and working capital; loan matures 5 years from Tranche A closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-068800","json":"https://secwatch.observer/filing/0001193125-22-068800.json","markdown":"https://secwatch.observer/filing/0001193125-22-068800.md","text":"https://secwatch.observer/filing/0001193125-22-068800.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1668243/000119312522068800/0001193125-22-068800-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1668243/000119312522068800/d302602d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T00:48:57.056002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}